Active Ingredient(s): Halobetasol
FDA Approved: * December 17, 1990
Pharm Company: * WESTWOOD SQUIBB
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ultravate Overview

Ulobetasol (INN) or halobetasol (USAN) is a corticosteroid used to treat psoriasis.[1][2] It is a class I corticosteroid under the US classification and a group III corticosteroid under international classification, the most potent group of such drugs.[3][4] Ulobetasol propionate is usually supplied as a 0.05% topical cream.[1] Ulobetasol is the strongest topical steroid available.[citation needed]...

Read more Ultravate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ulobetasol

Recent Ultravate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Cream: 0.05%
  • Lotion: 0.05%
  • Ointment: 0.05%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ultravate: (3 results)

Sorted by National Drug Code
  • 10631-102 Ultravate .5 mg/g Topical Ointment by Ranbaxy Laboratories Inc.
  • 10631-103 Ultravate .5 mg/g Topical Cream by Ranbaxy Laboratories Inc.
  • 10631-122 Ultravate .5 mg/g Topical Lotion by Ranbaxy Laboratories, Inc.

Other drugs which contain Halobetasol or a similar ingredient: (3 results)